Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 84,640 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 84,640 shares of the company’s stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $80.87, for a total transaction of $6,844,836.80. Following the completion of the transaction, the chief executive officer now owns 4,964,820 shares of the company’s stock, valued at approximately $401,504,993.40. This trade represents a 1.68 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Tempus AI Stock Down 10.5 %

TEM opened at $76.72 on Friday. The firm has a 50 day simple moving average of $49.75 and a 200 day simple moving average of $51.44. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $91.45.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on TEM shares. Wolfe Research started coverage on shares of Tempus AI in a research note on Friday, December 13th. They issued an “outperform” rating and a $60.00 price target for the company. Bank of America upped their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Guggenheim initiated coverage on shares of Tempus AI in a research note on Monday, December 9th. They set a “buy” rating and a $74.00 target price for the company. Finally, William Blair downgraded shares of Tempus AI from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $58.55.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Operose Advisors LLC acquired a new position in Tempus AI during the fourth quarter worth $25,000. First Horizon Advisors Inc. bought a new position in shares of Tempus AI in the third quarter valued at about $30,000. Farther Finance Advisors LLC bought a new position in shares of Tempus AI in the fourth quarter valued at about $34,000. Prestige Wealth Management Group LLC raised its position in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares during the period. Finally, NewEdge Advisors LLC acquired a new position in shares of Tempus AI in the fourth quarter valued at about $49,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.